PsychENCODE Consortium

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

The PsychENCODE Consortium was founded by the U.S. National Institutes of Health in 2015 to study the role of rare genetic variants involved in several psychiatric disorders. PsychENCODE aims to create a public resource of genomic data gathered from 1,000 healthy and disease-affected post-mortem brains reflecting different developmental periods.

PsychENCODE will first focus on autism spectrum disorder, bipolar disorder, and schizophrenia, and then move on to other disorders.[1]

Organizations

edit edit source

As of December 2018, participating organizations include:

References

edit edit source
  1. ^ Akbarian, S; Liu, C; Knowles, JA (2015). "The PsychENCODE project". Nat Neurosci. 18 (12): 1707–12. doi:10.1038/nn.4156. PMC 4675669. PMID 26605881.
  2. ^ "PsychENCODE". psychENCODE.org. Retrieved 2018-12-26.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1279521432 under CC BY-SA 4.0; modifications have been made.